144 related articles for article (PubMed ID: 17768733)
1. Amelioration of hyperglycemia and metabolic syndromes in type 2 diabetic KKA(y) mice by poly(gamma-glutamic acid)oxovanadium(IV) complex.
Karmaker S; Saha TK; Yoshikawa Y; Sakurai H
ChemMedChem; 2007 Nov; 2(11):1607-12. PubMed ID: 17768733
[TBL] [Abstract][Full Text] [Related]
2. A Zinc(II)/poly(gamma-glutamic acid) complex as an oral therapeutic for the treatment of type-2 diabetic KKAy mice.
Karmaker S; Saha TK; Yoshikawa Y; Sakurai H
Macromol Biosci; 2009 Mar; 9(3):279-86. PubMed ID: 18989849
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic activity of the orally effective vanadyl-poly (gamma-glutamic acid) complex in streptozotocin(STZ)-induced type 1 diabetic mice.
Karmaker S; Saha TK; Sakurai H
J Biomater Appl; 2008 Mar; 22(5):449-64. PubMed ID: 17494957
[TBL] [Abstract][Full Text] [Related]
4. Improvement of diabetes, obesity and hypertension in type 2 diabetic KKAy mice by bis(allixinato)oxovanadium(IV) complex.
Adachi Y; Yoshikawa Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
Biochem Biophys Res Commun; 2006 Jul; 345(3):945-50. PubMed ID: 16707105
[TBL] [Abstract][Full Text] [Related]
5. A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex.
Karmaker S; Saha TK; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2006 Sep; 100(9):1535-46. PubMed ID: 16824605
[TBL] [Abstract][Full Text] [Related]
6. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
Saha TK; Yoshikawa Y; Sakurai H
ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
[TBL] [Abstract][Full Text] [Related]
7. Improvement of hyperglycaemia and metabolic syndromes in type 2 diabetic KKAy mice by oral treatment with [meso-tetrakis(4-sulfonatophenyl) porphyrinato]oxovanadium(IV)(4-) complex.
Saha TK; Yoshikawa Y; Sakurai H
J Pharm Pharmacol; 2007 Mar; 59(3):437-44. PubMed ID: 17331348
[TBL] [Abstract][Full Text] [Related]
8. A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complex.
Yoshikawa Y; Adachi Y; Sakurai H
Life Sci; 2007 Jan; 80(8):759-66. PubMed ID: 17137606
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes.
Adachi Y; Yoshida J; Kodera Y; Kiss T; Jakusch T; Enyedy EA; Yoshikawa Y; Sakurai H
Biochem Biophys Res Commun; 2006 Dec; 351(1):165-70. PubMed ID: 17052688
[TBL] [Abstract][Full Text] [Related]
10. Chelation of vanadium(IV) by a natural and edible biopolymer poly(gamma-glutamic acid) in aqueous solution: structure and binding constant of complex.
Karmaker S; Saha TK
Macromol Biosci; 2008 Feb; 8(2):171-6. PubMed ID: 17941110
[TBL] [Abstract][Full Text] [Related]
11. Effects of insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex on diabetic rat model.
Hu R; He C; Liu J; Wu Y; Li J; Feng Z; Huang J; Xi XG; Wu Z
J Pharm Sci; 2010 Jul; 99(7):3041-7. PubMed ID: 20120019
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.
Shinde UA; Mehta AA; Goyal RK
Indian J Exp Biol; 2001 Sep; 39(9):864-70. PubMed ID: 11831366
[TBL] [Abstract][Full Text] [Related]
13. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
14. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
15. A new candidate for insulinomimetic vanadium complex: synergism of oxovanadium(IV)porphyrin and sodium ascorbate.
Sakurai H; Inohara T; Adachi Y; Kawabe K; Yasui H; Takada J
Bioorg Med Chem Lett; 2004 Mar; 14(5):1093-6. PubMed ID: 14980642
[TBL] [Abstract][Full Text] [Related]
16. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
17. Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
Eur J Pharmacol; 2009 Mar; 605(1-3):170-6. PubMed ID: 19171131
[TBL] [Abstract][Full Text] [Related]
18. Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice.
Kojima S; Asakawa A; Amitani H; Sakoguchi T; Ueno N; Inui A; Kalra SP
Peptides; 2009 May; 30(5):962-6. PubMed ID: 19428774
[TBL] [Abstract][Full Text] [Related]
19. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.
Jang SM; Yee ST; Choi J; Choi MS; Do GM; Jeon SM; Yeo J; Kim MJ; Seo KI; Lee MK
Int Immunopharmacol; 2009 Jan; 9(1):113-9. PubMed ID: 19013541
[TBL] [Abstract][Full Text] [Related]
20. Anti-diabetic effects of cesium aqua (N,N'-ethylene(salicylideneiminato)-5-sulfonato) oxovanadium (IV) dihydrate in streptozotocin-induced diabetic rats.
Li M; Wei D; Ding W; Baruah B; Crans DC
Biol Trace Elem Res; 2008 Mar; 121(3):226-32. PubMed ID: 17968514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]